Superior Trunk Block Applied for Upper Arm Surgery

Bursa Yüksek İhtisas Education and Research Hospital

Status: Completed

Conditions: Post Operative Pain

Treatments: Procedure: superior trunk block; Drug: intravenous patient-controlled analgesia

Study type: Interventional

Funder types: Other

Identifiers

NCT05474014

2022/06-12

Details and patient eligibility

About

Nerve blocks applied with ultrasonography are currently used for many post-operative pain and operations. Providing adequate area analgesia is the primary goal of clinicians, as early mobilization is suggested after shoulder and arm surgery.

In this study aimed to investigate the effect of superior trunk block application on postoperative analgesic and motor functions.

Enrollment: 60 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who were in the American Society of Anesthesiologists (ASA) I-III class
• Underwent upper arm surgery

Exclusion criteria

• Previous local anesthetic allergy,
• Having a bleeding diathesis disorder,
• Mental disorder,
• Allergic to the drugs used,
• Patients who did not consent to participate in the study,
• Presence of infection in the block area,
• Patients with a body mass index above 30

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

superior trunk block

Active Comparator group

Description:

Ultrasound guided superior trunk block with 10 ml % 0.25 bupivacaine + 400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

Treatment:

Procedure: superior trunk block

Drug: intravenous patient-controlled analgesia

tramadol

Active Comparator group

Description:

400 mg tramadol, IV 4 mg/ mL tramadol solution into 100 mL normal saline; PCA (patient-controlled analgesia): 0.3 mg/kg bolus, 10 mg Demand dose and 20 min lock out interval, six-hour limit infusion to attain 100 mg. Maximum daily dose was set at 400 mg.

Treatment:

Drug: intravenous patient-controlled analgesia